Metabolic labelling of cholesteryl glucosides in Helicobacter pylori reveals how the uptake of human lipids enhances bacterial virulence
Open Access
- 3 June 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 7 (9) , 6208-6216
Abstract
Helicobacter pylori infects approximately half of the human population and is the main cause of various gastric diseases. This pathogen is auxotrophic for cholesterol, which it converts upon uptake to various cholesteryl α-glucoside derivatives, including cholesteryl 6′-acyl and 6′-phosphatidyl α-glucosides (CAGs and CPGs). Owing to a lack of sensitive analytical methods, it is not known if CAGs and CPGs play distinct physiological roles or how the acyl chain component affects function. Herein we established a metabolite-labelling method for characterising these derivatives qualitatively and quantitatively with a femtomolar detection limit. The development generated an MS/MS database of CGds, allowing for profiling of all the cholesterol-derived metabolites. The subsequent analysis led to the unprecedented information that these bacteria acquire phospholipids from the membrane of epithelial cells for CAG biosynthesis. The resulting increase in longer or/and unsaturated CAG acyl chains helps to promote lipid raft formation and thus delivery of the virulence factor CagA into the host cell, supporting the idea that the host/pathogen interplay enhances bacterial virulence. These findings demonstrate an important connection between the chain length of CAGs and the bacterial pathogenicity.Keywords
Funding Information
- Academia Sinica
- Ministry of Science and Technology, Taiwan (99-213-M-001-006-MY3)
This publication has 46 references indexed in Scilit:
- Cholesterol Enhances Helicobacter pylori Resistance to Antibiotics and LL-37Antimicrobial Agents and Chemotherapy, 2011
- Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the hostProceedings of the National Academy of Sciences, 2011
- Helicobacter pylori Exploits Host Membrane Phosphatidylserine for Delivery, Localization, and Pathophysiological Action of the CagA OncoproteinCell Host & Microbe, 2010
- Line Active Hybrid Lipids Determine Domain Size in Phase Separation of Saturated and Unsaturated LipidsBiophysical Journal, 2010
- Role for α- l -fucosidase in the control of Helicobacter pylori -infected gastric cancer cellsProceedings of the National Academy of Sciences, 2009
- A Versatile Amino Acid Analogue of the Solvatochromic Fluorophore 4-N,N-Dimethylamino-1,8-naphthalimide: A Powerful Tool for the Study of Dynamic Protein InteractionsJournal of the American Chemical Society, 2008
- Cholesterol Depletion ReducesHelicobacter pyloriCagA Translocation and CagA-Induced Responses in AGS CellsInfection and Immunity, 2008
- 1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol -glucosyltransferase from Helicobacter pylori and suppresses H. pylori growthGlycobiology, 2008
- Helicobacter pylori and gastrointestinal tract adenocarcinomasNature Reviews Cancer, 2002
- Cholesterol binding of Helicobacter pyloriZentralblatt für Bakteriologie, 1992